ERYTECH provides financial update for Q3 2013 Post author:admERY Post published:November 5, 2013 Post category:Newsroom ERYTECH announces today its cash position and its revenues for the third quarter of 2013. You Might Also Like ERYTECH Presents Findings at European Red Cell Research Society Meeting March 11, 2019 Erytech announces trading suspension of its ordinary shares on Euronext Paris November 10, 2017 ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis February 8, 2021
